A new app developed by Cornell computer science researchers helps users record highly accurate time-lapse videos of body parts – a surprisingly difficult task and an unmet need in remote medicine and telehealth applications.
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.
The award funds innovative but inherently risky research endeavors that have the potential to overturn existing scientific paradigms or create new ones.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
For the first time, scientists have tracked the dispersion of the Oropouche virus in the Brazilian Amazon region, an important first step to control future outbreaks of a disease with more than 100,000 reported cases since the 1960s.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators.
A new protocol can detect and remove fake data created by bots and humans attempting to enroll in online research studies, in order to prevent biased results and unwarranted payments to bad actors – the first such protocol specifically designed for data collected in rural communities.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.